SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ARIAD Pharmaceuticals
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
4474 134 0 ARIA
Emcee:  jaybe Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3949You said "I've found about 5-6 others (kinases) that appear to match&quBiomaven-10/16/2015
3948I doubt its simply another EGFR resistant mutation inhibitor, having already desjaybe-10/16/2015
3947EGFR crowded space already, so unless this has something to significantly differBiomaven-10/16/2015
3946Interesting -- thanks. I guess EGFR qualifies as everything Clackson said reallglass 0.5 full-10/16/2015
3945Could be EGFR...does bear a resemblance to this view... [graphic][graphic] But jaybe-10/16/2015
3944I'm guessing it looks like the intracellular portion of EGFR. PeterBiomaven-10/16/2015
3943Any thoughts on what this might be? [graphic] Ariad says it's an image of glass 0.5 full-10/16/2015
3942Ponatinib as a RIPK2 inhibitor. So the real interest for me in RIPK2 inhibitioBiomaven-10/16/2015
3941It was stated to be a target that "others had tried and failed" so harBiomaven-10/9/2015
3940I rather doubt it will be that. Remember, Tim Clackson stated '788 will targtktom-10/9/2015
3939AP32788, I think it will likely to be a third generation irreversible EGFR inhibmedichem-10/9/2015
3938So how come Dr Cortez and the twenty plus top Oncologists did not agree with thcivic08801-10/4/2015
3937Take your pick it's either the Science and The Market that crashed ARIA or atktom-10/3/2015
3936 Dew and others ,Take your pick it's either the Science and The Market thacivic08801-10/2/2015
3935This is Silicon Investor, not Yahoo.DewDiligence_on_SI19/30/2015
3934IMHO when Harvey Berger told NVS he would not partner or consider a buyout all civic08801-9/30/2015
3933I hope you are right, but I'm not seeing it. I know the biotech sector has testad-9/29/2015
3932imho NVS and likely other BP want ARIA. Denner knows the value both NOW or whencivic08801-9/29/2015
3931Civic, You still believe that NVS is buying this company or that it will be sotestad-9/28/2015
3930Rigel sues Novartis over ceritinib... reuters.comjaybe-9/25/2015
3929Ariad's new HQ tenant is not exactly in unrelated field... xconomy.comjaybe-9/19/2015
3928ARIA will be sold soon at a high price,since IMHO more than one big pharma wantcivic08801-9/17/2015
3927Thanks Jaybe, much appreciated.testad-9/16/2015
3926I'm still expecting the '788 patent to publish by the end of this year. jaybe-9/15/2015
3925Has anybody heard anything about 788? I was under the impression that something testad-9/15/2015
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News